Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Avivo
Vancouver, British Columbia, Canada
- Ownership
- Private
- Development stage
- Other
01
Overview
Preclinical proof-of-concept studies, including ex vivo enzymatic conversion of blood type A human donor lungs to universal blood type for transplantation, have been published and support the feasibility of ABO antigen conversion in organs and blood products[2][3]. No clinical trials have yet been reported; the company is described as preclinical-stage[2][3][5][7].
- Therapeutic areas
- NephrologyHematologyImmunologyPulmonology
- Modalities
- Recombinant proteaseEnzyme replacement therapyBiologic
- Industry
- Biotech
02
Partnerships
University of British Columbia (Michael Smith Laboratories) – academic founding and ongoing collaboration on enzyme discovery and organ perfusion studies[2][3][4].Canadian Glycomics Network (GlycoNet) – non-dilutive funding and commercialization support for glycomics-based technology[2][6][8].Genome British Columbia – non-dilutive funding support[2].NRC-IRAP – non-dilutive funding support[2].MITACS – non-dilutive funding support[2].US Air Force (grant funding through UBC collaborators for related research)[2].
Beyond the preview
Go deeper on Avivo.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Avivo.